نتایج جستجو برای: intralesional glucantime

تعداد نتایج: 2601  

Journal: :Memorias do Instituto Oswaldo Cruz 2008
Eliane de Morais-Teixeira Alcione S de Carvalho Jorge C S da Costa Silvio L Duarte Jorge S Mendonça Núbia Boechat Ana Rabello

The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fiocruz, Brazil (TAMs), was assessed and compared to Glucantime-Aventis Pharma Ltda. Using the amastigote-like in vitro model, the active concentrations of Sb v varied from 10microg/ml to 300microg/ml for L. (L.) chagasi and from 50microg/ml to 300microg/ml for L. (L.) amazonensis, with no statistica...

2010
M Taran M Mohebali J Esmaeli

BACKGROUND Recent circumstantial evidences are suggesting that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime®). Pistacia atlantica is native plant in Iran (central, western, and eastern regions). Gum obtained Pistacia atlantica has been reported to possess considerable in vitro antimicrobial activity. In this study, w...

Journal: :The American journal of tropical medicine and hygiene 2005
Ellen M Andersen Maria Cruz-Saldarriaga Alejandro Llanos-Cuentas Maria Luz-Cjuno Juan Echevarria Cesar Miranda-Verastegui Olga Colina Jonathan D Berman

Pentamidine was compared with meglumine antimoniate (Glucantime) for 80 patients with cutaneous leishmaniasis due to Leishmania braziliensis in Peru. Of the 40 patients administered Glucantime (20 mg of antimony [Sb]/kg/day intravenously for 20 days), 31 cured (78%), 6 failed (15%), of which 5 were due to relapse, and 3 were lost to follow-up (7%). Of the 40 patients administered pentamidine (2...

2014
Abdolali Malmasi Bijan Ziaie Ardestani Mehdi Mohebali Behnaz Akhoundi Shadi Ziaie Majid Masoudifard Hamidreza Khorram Khorshid Mehdi Nasiri Saeed Bayanolhagh Ehsan Mostafavi Moin Delrobai Vahid Siavashi

Toxicity and drug resistance against pentavalent antimonials, medications of choice in treatment of leishmaniasis for more than 5 decades, have become important subjects globally. This study was a randomized, open labeled trial that was designed to determine efficacy and safety of IMOD as a novel herbal immunomodulator drug for treatment of canine visceral leishmaniasis (CVL). Twenty healthy mo...

Journal: :Journal of vector borne diseases 2008
M A Nilforoushzadeh L Shirani-Bidabadi A Zolfaghari-Baghbaderani S Saberi A H Siadat M Mahmoudi

BACKGROUND & OBJECTIVES Leishmaniasis is a parasitic disease transmitted by sand flies. Many investigations are performed to find an effective and safe treatment for leishmaniasis. In this study, we evaluated the efficacy of herbal extracts of Thymus vulgaris (Thyme) and Achillea millefolium (Yarrow), propolis hydroalcoholic extract and systemic glucantime against cutaneous leishmaniasis in Bal...

Journal: :Acta cirurgica brasileira 2005
Cecília Maria Carvalho Xavier Holanda Rodrigo Carvalho Holanda Leite Maria Teresa Jansem Catanho Grace Maria Lima Souza Mário Bernardo Filho

PURPOSE The labeling of red blood cells (C) with 99mTc is employed in clinical nuclear medicine for a variety of diagnostic procedures. Drugs can alter this labeling method and modify the disposition of the radiopharmaceuticals. In this paper, the influence of glucantime on the labeling of blood constituents with 9mTc was reported. METHODS Blood was withdrawn from rats and incubated with gluc...

2015
Lindon Johoson Diniz Silveira Thiago José Matos Rocha Sandra Aparecida Ribeiro Célia Maria Silva Pedrosa

INTRODUCTION Visceral leishmaniasis is an endemic protozoan found in Brazil. It is characterized by fever, pallor, hepatosplenomegaly, lymphadenopathy, and progressive weakness in the patient. It may lead to death if untreated. The drug of choice for treatment is meglumine antimoniate (Glucantime). The aim of this study was to evaluate patients with visceral leishmaniasis according to criteria ...

2016
Elham Gharirvand Eskandari Monir Doudi Saeid Abedi

Background and objective: Leishmaniasis is caused by protozoa of Leishmania genus and can be considered as a Zoonosis. The desease has caused the world health problems with high endemicity in developing countries such as Iran. Various chemical drugs have been used for leishmaniasis treatment, but their side effects and drug resistance haveled to look for new effective compounds. Medicago lupuli...

اخیانی, مریم , تاج سر, سید لیث ,

The World Health Organization estimates that approximately 400.000 new cases of Leishmaniasis occur worldwide each year. Cutaneous Leishmaniasis is an endemic disease in Iran. CL is caused by several species of Leishmania. Physical and Chemical Modalities have been used to treatment of cutaneous Leishmaniasis. Cryotherapy is a physical and interalesional glucantime is a chemical modality. In th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید